Victor A. Flores-Tamez

Victor A. Flores-Tamez

Auto-generated profile, based on publicly available information

Victor A. Flores-Tamez

Department of Pharmacology (V.A.F.), University of California, Davis

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2020 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
MNMadeline Nieves-Cintrón
Madeline Nieves-Cintrón
VFVíctor A. Flores-Tamez
Víctor A. Flores-Tamez
TLThanhmai Le
Thanhmai Le
MBMiguel Martín-Aragón Baudel
Miguel Martín-Aragón Baudel
MNManuel F. Navedo
Manuel F. Navedo
Diabetes affects millions of people worldwide. This devastating disease dramatically increases the risk of developing cardiovascular disorders. A hallmark metabolic abnormality in diabetes is hyperglycemia, which contributes to the pathogenesis of cardiovascular complications. These cardiovascular complications are, at least in part, related to hyperglycemia-induced molecular and cellular changes in the cells making up blood vessels. Whereas the mechanisms mediating endothelial dysfunction during hyperglycemia have been extensively examined, much less is known about how hyperglycemia impacts vascular smooth muscle function. Vascular smooth muscle function is exquisitely regulated by many ion channels, including several members of the potassium (K+) channel superfamily and voltage-gated L-type Ca2+channels. Modulation of vascular smooth muscle ion channels function by hyperglycemia is emerging as a key contributor to vascular dysfunction in diabetes. In this review, we summarize the current understanding of how diabetic hyperglycemia modulates the activity of these ion channels in vascular smooth muscle. We examine underlying mechanisms, general properties, and physiological relevance in the context of myogenic tone and vascular reactivity.

20 October 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MPMaria Paz Prada
Maria Paz Prada
ASArsalan U. Syed
Arsalan U. Syed
GRGopireddy R. Reddy
Gopireddy R. Reddy
MBMiguel Martin Aragon Baudel
Miguel Martin Aragon Baudel
VFVíctor A. Flores-Tamez
Víctor A. Flores-Tamez
MNMadeline Nieves-Cintron
Madeline Nieves-Cintron
The L-type Ca2+ channel CaV1.2 is essential for arterial myocyte excitability, gene expression and contraction. Elevations in extracellular glucose (hyperglycemia) potentiate vascular L-type Ca2+ channel via PKA, but the underlying mechanisms are unclear. Here, we find that cAMP synthesis in response to elevated glucose and the selective P2Y11 agonist NF546 is blocked by disruption of A-kinase anchoring protein 5 (AKAP5) function in arterial myocytes. Glucose and NF546-induced potentiation of L-type Ca2+ channels, vasoconstriction and decreased blood flow are prevented in AKAP5 null arterial myocytes/arteries. These responses are nucleated via the AKAP5-dependent clustering of P2Y11/ P2Y11-like receptors, AC5, PKA and CaV1.2 into nanocomplexes at the plasma membrane of human and mouse arterial myocytes. Hence, data reveal an AKAP5 signaling module that regulates L-type Ca2+ channel activity and vascular reactivity upon elevated glucose. This AKAP5-anchored nanocomplex may contribute to vascular complications during diabetic hyperglycemia.

8 November 2022 in Circulation Research
Verified
Journal Article
Open access
PDF file
MBMiguel Martin Aragon Baudel
Miguel Martin Aragon Baudel
VFVictor A. Flores-Tamez
Victor A. Flores-Tamez
JHJunyoung Hong
Junyoung Hong
GRGopyreddy R. Reddy
Gopyreddy R. Reddy
PMPauline Maillard
Pauline Maillard
MNManuel F. Navedo
Manuel F. Navedo
Background: L-type Ca V 1.2 channels undergo cooperative gating to regulate cell function, although mechanisms are unclear. This study tests the hypothesis that phosphorylation of the Ca V 1.2 pore-forming subunit α1 C at S1928 mediates vascular Ca V 1.2 cooperativity during diabetic hyperglycemia. Methods: A multiscale approach including patch-clamp electrophysiology, super-resolution nanoscopy, proximity ligation assay, calcium imaging‚ pressure myography, and Laser Speckle imaging was implemented to examine Ca V 1.2 cooperativity, α1 C clustering, myogenic tone, and blood flow in human and mouse arterial myocytes/vessels. Results: Ca V 1.2 activity and cooperative gating increase in arterial myocytes from patients with type 2 diabetes and type 1 diabetic mice, and in wild-type mouse arterial myocytes after elevating extracellular glucose. These changes were prevented in wild-type cells pre-exposed to a PKA inhibitor or cells from knock-in S1928A but not S1700A mice. In addition, α1 C clustering at the surface membrane of wild-type, but not wild-type cells pre-exposed to PKA or P2Y 11 inhibitors and S1928A arterial myocytes, was elevated upon hyperglycemia and diabetes. Ca V 1.2 spatial and gating remodeling correlated with enhanced arterial myocyte Ca 2+ influx and contractility and in vivo reduction in arterial diameter and blood flow upon hyperglycemia and diabetes in wild-type but not S1928A cells/mice. Conclusions: These results suggest that PKA-dependent S1928 phosphorylation promotes the spatial reorganization of vascular α1 C into “superclusters” upon hyperglycemia and diabetes. This triggers Ca V 1.2 activity and cooperativity, directly impacting vascular reactivity. The results may lay the foundation for developing therapeutics to correct Ca V 1.2 and arterial function during diabetic hyperglycemia.

15 October 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
VFVictor A. Flores‐Tamez
Victor A. Flores‐Tamez
MBMiguel Martin Aragon Baudel
Miguel Martin Aragon Baudel
JHJunyoung Hong
Junyoung Hong
JTJade L. Taylor
Jade L. Taylor
LRLU Ren
LU Ren
MNManuel F. Navedo
Manuel F. Navedo
Background: Increased vascular Ca V 1.2 channel function causes enhanced arterial tone during hypertension. This is mediated by elevations in angiotensin II/protein kinase C signaling. Yet, the mechanisms underlying these changes are unclear. We hypothesize that α1 C phosphorylation at serine 1928 (S1928) is a key event mediating increased Ca V 1.2 channel function and vascular reactivity during angiotensin II signaling and hypertension. Methods and Results: The hypothesis was examined in freshly isolated mesenteric arteries and arterial myocytes from control and angiotensin II‐infused mice. Specific techniques include superresolution imaging, proximity ligation assay, patch‐clamp electrophysiology, Ca 2+ imaging, pressure myography, laser speckle imaging, and blood pressure telemetry. Hierarchical “nested” and appropriate parametric or nonparametric t test and ANOVAs were used to assess statistical differences. We found that angiotensin II redistributed the Ca V 1.2 pore‐forming α1 C subunit into larger clusters. This was correlated with elevated Ca V 1.2 channel activity and cooperativity, global intracellular Ca 2+ and contraction of arterial myocytes, enhanced myogenic tone, and altered blood flow in wild‐type mice. These angiotensin II‐induced changes were prevented/ameliorated in cells/arteries from S1928 mutated to alanine knockin mice, which contain a negative modulation of the α1 C S1928 phosphorylation site. In angiotensin II‐induced hypertension, increased α1 C clustering, Ca V 1.2 activity and cooperativity, myogenic tone, and blood pressure in wild‐type cells/tissue/mice were averted/reduced in S1928 mutated to alanine samples. Conclusions: Results suggest an essential role for α1 C S1928 phosphorylation in regulating channel distribution, activity and gating modality, and vascular function during angiotensin II signaling and hypertension. Phosphorylation of this single vascular α1 C amino acid could be a risk factor for hypertension that may be targeted for therapeutic intervention.

1 January 2019 in Folia Biologica
Verified
Journal Article
Open access
PDF file
VFV. Flores-Tamez
V. Flores-Tamez
BEB. Escalante
B. Escalante
ARAmelia Rios
Amelia Rios
Several studies have shown that peroxynitrite (ONOO – ), formed upon the reaction of •NO and O 2– , is increased in many cardiovascular diseases and is detrimental to myocardial function. Proteins associated with Ca 2+ homeostasis regulation in the heart may be involved in these effects. Thus, the aim of this study was to elucidate the mechanisms associated with ONOO – -induced effects. We evaluated [Ca 2+ ] i regulation, sarco/endoplasmic reticulum Ca 2+ - binding proteins, and phosphorylation levels of the ryanodine receptor in isolated rat myocytes. Electrical field-induced intracellular Ca 2+ transients and contractions were recorded simultaneously. Myocytes superfused with 3-morpholinosydnonimine N-ethylcarbamide (SIN-1), an ONOO – donor, decreased the amplitude of Ca 2+ transients and contraction in a dose-response (1–200 μM) manner. Similarly, SIN-1 increased half-time decay in a concentration-dependent manner. Co-infusion of the ONOO – donor with FeTMPyP (1 μM), an ONOO – decomposition catalyst, inhibited the effects induced by ONOO – . Impaired sarcoplasmic reticulum Ca 2+ uptake caused by ONOO – (SIN-1 200 μM) was confirmed by a reduction of caffeine-evoked Ca 2+ release along with prolongation of the half-time decay. Surprisingly, ONOO – induced a spontaneous Ca 2+ transient that started at the beginning of the relaxation phase and was inhibited by tetracaine. Also, reduced phosphorylation at the ryanodine receptor 2 (RyR2)-Ser-2814 site was observed. In conclusion, deficient sarco/endoplasmic reticulum Ca2+-ATPase-mediated Ca 2+ uptake concomitant with augmented Ca 2+ release by RyR2 in myocytes may be associated with modification of myocyte Ca 2+ handling by ONOO – . Thus, development of cardiac failure in diabetes, nephropathy, or hypertension may be related with elevated ONOO – in cardiac tissue.

19 June 2026 in Circulation Research
Verified
Journal Article
Open access
OVOscar Vivas
Oscar Vivas
MBMatthias Baudot
Matthias Baudot
RMRoxanne Madden
Roxanne Madden
WPWendy L. Pinon-Teal
Wendy L. Pinon-Teal
MHMartina S. Hunt
Martina S. Hunt
CMClaudia M. Moreno
Claudia M. Moreno
BACKGROUND: Every heartbeat is initiated by a spontaneous electrical signal generated inside the cardiac pacemaker. This signal depends on the coordinated activity of ion channels, where voltage-gated L-type calcium channels play a central role. All mammals experience a progressive decline in pacemaker rate with age, which in humans can become pathological and drive the need for artificial pacemaker implantation. Yet the mechanisms underlying this age-associated slowdown remain incompletely understood. METHODS: We combined patch-clamp electrophysiology, single-channel recording, calcium imaging, immunocytochemistry, and super-resolution microscopy to investigate L-type calcium channel density, organization, and function in sinoatrial node pacemaker cells from young and old mice. RESULTS: Aging reduced L-type calcium channel density at the plasma membrane, disrupted channel clustering, and decreased open probability, collectively diminishing calcium current density by 50%. Pharmacological enhancement of channel open probability with Bay K 8644 was sufficient to accelerate diastolic depolarization and restore pacemaker rate in old cells to young levels. These channel alterations were paralleled by a decline in caveolin-3 expression. Disrupting caveolae in young cells recapitulated the loss of channel clustering, pointing to caveolae as a structural basis for the age-associated channel alterations. CONCLUSIONS: Aging impairs L-type calcium channel organization and function in cardiac pacemaker cells. This impairment is mediated by an age-associated reduction of caveolae, key membrane microdomains for channel organization. The resulting decline in L-type calcium channel density and activity is an important driver of the age-associated slowdown of the cardiac pacemaker.